| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10907499 | Experimental Hematology | 2005 | 8 Pages |
Abstract
We have shown that low-dose alemtuzumab is effective for GVHD prevention, but its use still impairs the immune reconstitution.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Anna Dodero, Matteo Carrabba, Raffaella Milani, Elena Rizzo, Anna Raganato, Vittorio Montefusco, Lucia Farina, Marco Milanesi, Paolo Longoni, Carmelo Carlo-Stella, Paolo Corradini,